Elite Pharma President Steps Down

Chris Dick will step down as president and chief operating officer and as a member of the board of directors at Elite Pharmaceuticals, Inc., effective May 24, 2013. Mr. Dick will remain as a consultant to help ensure a smooth transition while the board seeks a permanent replacement.
 
“We thank Chris for his contributions to Elite, especially the passion, dedication and energy he brought to the Company every single day,” said Jerry Treppel, Elite’s chairman and chief executive officer. “Chris has worked hard to successfully turn the company around through very challenging circumstances, secured two very important patents for our abuse deterrent technology and advanced the development of this technology through commercial scale up. We appreciate Chris’ leadership and the many important strategic initiatives he has achieved for the company.”
 
Mr. Dick said, “Elite is an outstanding company with creative and talented employees. I am proud of what we have accomplished together. I feel it is the right time for me to pass the baton and let new leadership take the Company into its next phase with the abuse deterrent technology. I remain very optimistic about Elite’s future.”